scholarly journals Immune-enhancing effects of Lactobacillus plantarum 200655 isolated from Korean kimchi in a cyclophosphamide-induced immunocompromised mouse model

Author(s):  
Kyeong Jin Kim ◽  
Hyun-Dong Paik ◽  
Ji Yeon Kim
2019 ◽  
Vol 10 (2) ◽  
pp. 352-359 ◽  
Author(s):  
Geoffrey E. Lynn ◽  
Nicole E. Breuner ◽  
Lars Eisen ◽  
Andrias Hojgaard ◽  
Adam J. Replogle ◽  
...  

2017 ◽  
Vol 86 (3) ◽  
Author(s):  
Anna Sintsova ◽  
Sara Smith ◽  
Sargurunathan Subashchandrabose ◽  
Harry L. Mobley

ABSTRACTUrinary tract infection (UTI) is the second most common infection in humans, making it a global health priority. Nearly half of all women will experience a symptomatic UTI, with uropathogenicEscherichia coli(UPEC) being the major causative agent of the infection. Although there has been extensive research on UPEC virulence determinants, the importance of host-specific metabolism remains understudied. We report here that UPEC upregulates the expression of ethanolamine utilization genes during uncomplicated UTIs in humans. We further show that UPEC ethanolamine metabolism is required for effective bladder colonization in the mouse model of ascending UTI and is dispensable for bladder colonization in an immunocompromised mouse model of UTI. We demonstrate that although ethanolamine metabolism mutants do not show increased susceptibility to antimicrobial responses of neutrophils, this metabolic pathway is important for surviving the innate immune system during UTI. This study reveals a novel aspect of UPEC metabolism in the host and provides evidence for an underappreciated link between bacterial metabolism and the host immune response.


2018 ◽  
Vol 11 (3) ◽  
pp. 910-920 ◽  
Author(s):  
Diwas Pradhan ◽  
Rajbir Singh ◽  
Ashish Tyagi ◽  
Rashmi H.M. ◽  
Virender K. Batish ◽  
...  

2012 ◽  
Vol 18 (12) ◽  
pp. 1820-1826 ◽  
Author(s):  
Rachel L Graham ◽  
Michelle M Becker ◽  
Lance D Eckerle ◽  
Meagan Bolles ◽  
Mark R Denison ◽  
...  

2020 ◽  
Vol 11 (11) ◽  
Author(s):  
Hai-Jun Hu ◽  
Xiu Liang ◽  
Hai-Lang Li ◽  
Chun-Ming Du ◽  
Jia-Li Hao ◽  
...  

AbstractZD55-IL-24 is similar but superior to the oncolytic adenovirus ONYX-015, yet the exact mechanism underlying the observed therapeutic effect is still not well understood. Here we sought to elucidate the underlying antitumor mechanism of ZD55-IL-24 in both immunocompetent and immunocompromised mouse model. We find that ZD55-IL-24 eradicates established melanoma in B16-bearing immunocompetent mouse model not through the classic direct killing pathway, but mainly through the indirect pathway of inducing systemic antitumor immunity. Inconsistent with the current prevailing view, our further results suggest that ZD55-IL-24 can induce antitumor immunity in B16-bearing immunocompetent mouse model in fact not due to its ability to lyse tumor cells and release the essential elements, such as tumor-associated antigens (TAAs), but due to its ability to put a “nonself” label in tumor cells and then turn the tumor cells from the “self” state into the “nonself” state without tumor cell death. The observed anti-melanoma efficacy of ZD55-IL-24 in B16-bearing immunocompetent mouse model was practically caused only by the viral vector. In addition, we also notice that ZD55-IL-24 can inhibit tumor growth in B16-bearing immunocompetent mouse model through inhibiting angiogenesis, despite it plays only a minor role. In contrast to B16-bearing immunocompetent mouse model, ZD55-IL-24 eliminates established melanoma in A375-bearing immunocompromised mouse model mainly through the classic direct killing pathway, but not through the antitumor immunity pathway and anti-angiogenesis pathway. These findings let us know ZD55-IL-24 more comprehensive and profound, and provide a sounder theoretical foundation for its future modification and drug development.


2011 ◽  
Vol 39 (4) ◽  
pp. 4765-4775 ◽  
Author(s):  
Raj Kumar Duary ◽  
Mache Amit Bhausaheb ◽  
Virender Kumar Batish ◽  
Sunita Grover

Sign in / Sign up

Export Citation Format

Share Document